112
Views
1
CrossRef citations to date
0
Altmetric
Middle ear

Cholesteatoma in chronic otitis media secondary to pars tensa perforation

, , ORCID Icon, &
Pages 376-381 | Received 05 Dec 2022, Accepted 23 Mar 2023, Published online: 21 Apr 2023

References

  • Meyerhoff WL, Truelson J. Cholesteatoma staging. Laryngoscope. 1986;96(9 Pt 1):935–939.
  • Nelson G, Sara C, Tiago C, et al. Middle ear congenital cholesteatoma: systematic review, meta-analysis and insights on its pathogenesis. Eur Arch Otorhinolaryngol. 2020;277(4):987–998.
  • Louw L. Acquired cholesteatoma pathogenesis: stepwise explanations. J Laryngol Otol. 2010;124(6):587–593.
  • Oktay MF, Cureoglu S, Schachern PA, et al. Tympanic membrane changes in central tympanic membrane perforations. Am J Otolaryngol. 2005;26(6):393–397.
  • Nagai T, Suganuma T, Ide S, et al. Confirmation of mucin in lymphatic vessels of acquired cholesteatoma. Eur Arch Otorhinolaryngol. 2006;263(4):361–364.
  • Sudhoff H, Tos M. Pathogenesis of sinus cholesteatoma. Eur Arch Otorhinolaryngol. 2007;264(10):1137–1143.
  • Huisman MA, de Heer E, Dijke PT, et al. Transforming growth factor b and wound healing in human cholesteatoma. Laryngoscope. 2008;118(1):94–98.
  • Rosito LS, Netto LF, Teixeira AR, et al. Classification of cholesteatoma according to growth patterns. JAMA Otolaryngol Head Neck Surg. 2016;142(2):168–172.
  • Yung M, Tono T, Olszewska E, et al. EAONO/JOS joint consensus statements on the definitions, classification and staging of Middle ear cholesteatoma. J Int Adv Otol. 2017;13(1):1–8.
  • Yamamoto Y, Takahashi K, Morita Y, et al. Clinical behavior and pathogenesis of secondary acquired cholesteatoma with a tympanic membrane perforation. Acta Otolaryngol. 2013;133(10):1035–1039.
  • Zhang J, Zhong Z, Xiao S, et al. Tubomanometry value as an associated factor for medication outcomes in adult acute otitis media with effusion. Eur Arch Otorhinolaryngol. 2018;275(1):53–57.
  • Ockermann T, Reineke U, Upile T, et al. Balloon dilation eustachian tuboplasty: a feasibility study. Otol Neurotol. 2010;31(7):1100–1103.
  • Masaki M, Wright CG, Lee DH, et al. Experimental cholesteatoma. Epidermal ingrowth tympanic membrane following middle ear application of propylene glycol. Acta Otolaryngol. 1989;108(1–2):113–121.
  • Jackler RK, Santa Maria PL, Varsak YK, et al. A new theory on the pathogenesis of acquired cholesteatoma: mucosal traction. Laryngoscope. 2015;125 Suppl 4(Suppl 4):S1–S14.
  • Sudhoff H, Bujia J, Holly A, et al. Functional characterization of middle ear mucosa residues in cholesteatoma samples. Am J Otol. 1994;15(2):217–221.
  • Ong CA, Narayanan P, Godbole S, et al. Epithelial migration in open mastoidectomy cavities. Asian J Surg. 2007;30(1):57–59.
  • Kim HJ, Tinling SP, Chole RA. Increased proliferation and migration of epithelium in advancing experimental cholesteatomas. Otol Neurotol. 2002;23(6):840–844.
  • Santa Maria PL, Redmond SL, McInnes RL, et al. Tympanic membrane wound healing in rats assessed by transcriptome profiling. Laryngoscope. 2011;121(10):2199–2213.
  • Sadé J, Fuchs C. A comparison of mastoid pneumatization in adults and children with cholesteatoma. Eur Arch Otorhinolaryngol. 1994;251(4):191–195.
  • Ramakrishnan Y, Kotecha A, Bowdler DA. A review of retraction pockets: past, present and future management. J Laryngol Otol. 2007;121(6):521–525.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.